ATE469674T1 - 5-aminolävulinsäure-derivate zur behandlung von akne - Google Patents

5-aminolävulinsäure-derivate zur behandlung von akne

Info

Publication number
ATE469674T1
ATE469674T1 AT05800149T AT05800149T ATE469674T1 AT E469674 T1 ATE469674 T1 AT E469674T1 AT 05800149 T AT05800149 T AT 05800149T AT 05800149 T AT05800149 T AT 05800149T AT E469674 T1 ATE469674 T1 AT E469674T1
Authority
AT
Austria
Prior art keywords
acne
treatment
acid derivatives
aminolevulic acid
aminolevulic
Prior art date
Application number
AT05800149T
Other languages
German (de)
English (en)
Inventor
Aslak Godal
Jo Klaveness
Hilde Morris
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Application granted granted Critical
Publication of ATE469674T1 publication Critical patent/ATE469674T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)
AT05800149T 2004-11-10 2005-11-04 5-aminolävulinsäure-derivate zur behandlung von akne ATE469674T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424833A GB0424833D0 (en) 2004-11-10 2004-11-10 Method
PCT/GB2005/004253 WO2006051269A1 (en) 2004-11-10 2005-11-04 Treatment of acne using derivatives of 5-aminolevulinic acid

Publications (1)

Publication Number Publication Date
ATE469674T1 true ATE469674T1 (de) 2010-06-15

Family

ID=33523497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05800149T ATE469674T1 (de) 2004-11-10 2005-11-04 5-aminolävulinsäure-derivate zur behandlung von akne

Country Status (16)

Country Link
US (2) US20080188558A1 (enExample)
EP (1) EP1814534B1 (enExample)
JP (1) JP5134370B2 (enExample)
CN (1) CN101056626B (enExample)
AT (1) ATE469674T1 (enExample)
AU (1) AU2005303565B2 (enExample)
CA (1) CA2586195C (enExample)
DE (1) DE602005021677D1 (enExample)
DK (1) DK1814534T3 (enExample)
ES (1) ES2344986T3 (enExample)
GB (1) GB0424833D0 (enExample)
PL (1) PL1814534T3 (enExample)
PT (1) PT1814534E (enExample)
RU (1) RU2385718C2 (enExample)
SI (1) SI1814534T1 (enExample)
WO (1) WO2006051269A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
US20110224598A1 (en) * 2010-03-12 2011-09-15 Daniel Barolet Radiant near infrared light emitting diode exposure as skin preparation
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
KR100796450B1 (ko) 2006-06-29 2008-01-22 전남대학교산학협력단 5-아미노레불린산의 불포화 알킬 에스터 및 약학적으로허용되는 그의 염, 이의 제조방법 및 이의 용도
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
WO2009003173A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodymanic therapy
JP2011506425A (ja) * 2007-12-14 2011-03-03 フォトデルマ エスアー 治療的及び美容的方法に有用な新規化合物
GB0823265D0 (en) * 2008-12-20 2009-01-28 Convatec Technologies Inc Antimicrobial Composition
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
CN102458388B (zh) 2009-06-11 2016-09-28 光治疗Asa公司 半固体组合物及药物制品
JP2013521251A (ja) 2010-03-01 2013-06-10 フォトキュア エイエスエイ 美容組成物
EP2585111A1 (en) 2010-06-23 2013-05-01 Photocure ASA Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
BR112013000613A2 (pt) 2010-07-09 2016-06-28 Photocure Asa composições secas e dispositivos que contêm tais composições secas
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
PL3222266T3 (pl) 2010-08-27 2018-10-31 Sienna Biopharmaceuticals, Inc. Kompozycje i sposoby do termomodulacji celowanej
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
CN104152530B (zh) 2010-12-24 2017-09-19 爱科来株式会社 癌细胞的检测方法
KR101308652B1 (ko) * 2011-05-19 2013-09-13 제너럴바이오(주) Ｍａｌ을 이용한 여드름 치료 조성물
EP2779956A1 (en) 2011-10-14 2014-09-24 Photocure ASA Stent
US20140276107A1 (en) 2011-10-14 2014-09-18 Photocure Asa Photodynamic diagnosis
WO2013092505A1 (en) 2011-12-19 2013-06-27 Photocure Asa Irradiation apparatus
WO2013092936A2 (en) * 2011-12-20 2013-06-27 Galderma Research & Development Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
WO2014020164A1 (en) * 2012-08-03 2014-02-06 Photocure Asa Compounds
CA2881439C (en) * 2012-08-10 2017-08-29 Dusa Pharmaceuticals, Inc. Method for the treatment of acne
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
EP2906286B1 (en) 2012-10-11 2017-06-14 Nanocomposix, Inc. Silver nanoplate compositions and methods
JP2016507663A (ja) 2012-12-20 2016-03-10 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 化学修飾セルロース系繊維の加工
KR101623553B1 (ko) * 2013-07-23 2016-05-23 동성제약주식회사 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
BR112016014073A2 (pt) 2013-12-20 2017-08-08 Galderma Res & Dev Tratamento fotodinâmico de pulso de pele fotodanificada
CA2935865A1 (en) 2014-01-10 2015-07-16 Sebacia, Inc. Treatment intervals for use of compositions comprising energy absorbing materials for dermatological applications
US9956426B2 (en) 2015-02-26 2018-05-01 Amol Punjabi Upconverting nanoparticles
US20160287615A1 (en) * 2015-04-03 2016-10-06 BioPharmX, Inc. Novel encapsulation of fluorescent, photo-sensitive, or oxygen-sensitive active ingredient for topical application
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
EP3851161A1 (en) 2015-10-15 2021-07-21 DUSA Pharmaceuticals, Inc. Adjustable illuminator for photodynamic therapy and diagnosis
CN106801037B (zh) * 2017-01-06 2021-01-19 中国人民解放军南京军区福州总医院 体外痤疮炎症模型的建立方法及其应用
US10632324B2 (en) 2017-04-27 2020-04-28 9127-4910 Quebec Inc. Method for the treatment of skin tissues
AU2018302103B2 (en) * 2017-07-17 2024-03-07 Sun Pharmaceutical Industries, Inc. Photodynamic therapy method for skin disorders
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
KR102171200B1 (ko) * 2018-11-20 2020-10-28 제너럴바이오(주) 5-아미노레불린산 수화염화물과 그 유도체를 유효성분으로 함유하는 여드름성 피부염 개선 또는 그의 조성물
KR102265592B1 (ko) * 2020-10-29 2021-06-17 김진왕 5-아미노레불린산 수화염화물을 포함하는 조성물
KR20250021825A (ko) 2023-08-07 2025-02-14 주식회사 아스트로젠 5-아미노레불린산 유도체 및 이를 포함하는 약학 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5713845A (en) * 1991-10-29 1998-02-03 Thermolase Corporation Laser assisted drug delivery
EP0660712B1 (en) 1992-09-21 2001-05-30 Quadra Logic Technologies Inc. Transcutaneous in vivo activation of photosensitive agents in blood
FR2714602B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
CZ291132B6 (cs) * 1995-03-10 2002-12-11 Photocure Asa Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
US6183773B1 (en) * 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
CA2422865C (en) * 2000-08-16 2012-10-16 The General Hospital Corporation D/B/A Massachusetts General Hospital Aminolevulinic acid photodynamic therapy for treating sebaceous gland disorders
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method
WO2003039597A1 (en) * 2001-11-09 2003-05-15 Qlt Inc. Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
US20050209331A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
US20050209330A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds

Also Published As

Publication number Publication date
JP5134370B2 (ja) 2013-01-30
US20130066256A1 (en) 2013-03-14
CN101056626A (zh) 2007-10-17
US20080188558A1 (en) 2008-08-07
RU2007115601A (ru) 2008-12-20
CA2586195C (en) 2013-12-31
EP1814534A1 (en) 2007-08-08
AU2005303565A1 (en) 2006-05-18
ES2344986T3 (es) 2010-09-13
JP2008519812A (ja) 2008-06-12
DE602005021677D1 (de) 2010-07-15
PL1814534T3 (pl) 2010-11-30
EP1814534B1 (en) 2010-06-02
SI1814534T1 (sl) 2010-09-30
PT1814534E (pt) 2010-06-15
RU2385718C2 (ru) 2010-04-10
CN101056626B (zh) 2011-12-14
AU2005303565B2 (en) 2011-04-14
GB0424833D0 (en) 2004-12-15
WO2006051269A1 (en) 2006-05-18
US8546447B2 (en) 2013-10-01
CA2586195A1 (en) 2006-05-18
DK1814534T3 (da) 2010-09-20

Similar Documents

Publication Publication Date Title
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
DE60320007D1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
CY1115940T1 (el) Παραγωγα υποκατεστημενου φαινυλαλκανοϊκου οξεος και η χρηση τους για τη θεραπευτικη αντιμετωπιση αναπνευστικων ασθενειων
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
EP1192949A4 (en) PREVENTIVE OR THERAPEUTIC DRUGS FOR TREATING FIBROSIS AND CONTAINING CHYMASE INHIBITORS AS ACTIVE INGREDIENTS
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
CY1106385T1 (el) Χρηση παραγωγων της εποθειλονης για τη θepαπεια του υπepπαραθυρεοειδισμου
WO2006133231A3 (en) Treatment for neurodegenerative diseases
BRPI0509881A (pt) combinação terapêutica para tratamento da doença de alzheimer
ATE464042T1 (de) Verwendung von neboglamine zur behandlung von schizophrenie
ATE442848T1 (de) Isoxazolsäure-derivat zur linderung neuropathischer schmerzen
WO2008149971A1 (ja) 脳動脈瘤の治療または予防薬
ATE520666T1 (de) Derivate von 18-amino-substituierten analoga des geldamycin-hydrochinons mit cyctotoxischer wirkung für die behandlung von krebs
TH100046A (enExample)
WO2010062144A3 (ko) 에타크리닉 산을 포함하는 트란스글루타미나제 관련 질환 예방 또는 치료용 조성물 및 그를 이용하는 트란스글루타미나제 관련 질환 예방 또는 치료 방법
TH103569A (th) อนุพันธ์ของ6-ไพริมิดินิล-ไพริมิด-2-โอน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1814534

Country of ref document: EP